SCHEMBL18156667

SCHEMBL18156667

Cc1ccc2c(c1)C1(c3cc(C)ccc3-2)c2ccccc2-c2ccc3oc4ccccc4c3c21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 3/20 0.40
MAOB P27338 4/20 0.38
MAOA P21397 2/20 0.38
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 3/20 0.33
HPGD P15428 3/20 0.33
HSD17B10 Q99714 2/20 0.33
TNKS O95271 1/20 0.33
PARP1 P09874 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
PARP2 Q9UGN5 1/20 0.33
GAA P10253 1/20 0.33
POLB P06746 1/20 0.33
LMNA P02545 2/20 0.33
MAPT P10636 2/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
ALOX5 P09917 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17879492 0.89 KDM4E (0.37) MAOAKDM4EALDH1A1HPGDHSD17B10
SCHEMBL22930708 0.86 KDM4E (0.35) MAOAKDM4EALDH1A1HPGDHSD17B10
SCHEMBL21742874 0.85 PDK2 (0.39) PDK2MAOBMAOAKDM4EALDH1A1
SCHEMBL21742870 0.85 PDK2 (0.39) PDK2MAOBMAOAKDM4EALDH1A1
SCHEMBL18034352 0.85 PDK2 (0.38) PDK2MAOBMAOAKDM4EALDH1A1
SCHEMBL18034420 0.85 PDK2 (0.38) PDK2MAOBMAOAKDM4EALDH1A1
SCHEMBL18156670 0.84 ALOX5 (0.44) PDK2MAOBMAOAALDH1A1TNKS
SCHEMBL19299468 0.84 KDM4E (0.35) MAOAKDM4EALDH1A1HPGDHSD17B10
SCHEMBL22930716 0.84 PDK2 (0.37) PDK2MAOBMAOAKDM4EALDH1A1
SCHEMBL20224548 0.83 PDK2 (0.39) PDK2MAOAKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2023-04-27 US disclosed
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 PDK2 264/4885MAOB 2889/4885MAOA 3085/4885
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 PDK2 264/4885MAOB 2889/4885MAOA 3085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.